Clinical Trial Update: The Efficacy, Safety and Genetic Polymorphism of Hypoca and Adalat OROS in Hypertensive Patients

View source ↗

Summary

A completed clinical trial evaluating the efficacy, safety and genetic polymorphism of Hypoca and Adalat OROS in hypertensive patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Adalat OROS (nifedipine)
• Hypoca

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Hypertension | Status: COMPLETED